Results 51 to 60 of about 4,423,512 (307)

MRI Staging in Locally Advanced Vulvar Cancer: From Anatomy to Clinico-Radiological Findings. A Multidisciplinary VulCan Team Point of View

open access: yesJournal of Personalized Medicine, 2021
MR imaging provides excellent spatial and contrast resolution to stage locally advanced vulvar cancer (LAVC) for tumor and nodal evaluation in order to facilitate the planning of treatment.
B. Gui   +13 more
semanticscholar   +1 more source

Immunotherapy for recurrent or metastatic vulvar carcinoma: A case report and review of current guidelines

open access: yesGynecologic Oncology Reports, 2022
There are limited treatment options for patients with advanced vulvar cancer. However, several immune checkpoint inhibitors (ICIs) are FDA-approved or NCCN-Compendia–listed for qualified patients with advanced disease.
Aaron Praiss   +5 more
doaj  

Ultrasound morphometric and cytologic preoperative assessment of inguinal lymph‐node status in women with vulvar cancer: MorphoNode study

open access: yesUltrasound in Obstetrics and Gynecology, 2020
To assess the accuracy of preoperative ultrasound examination for predicting lymph‐node (LN) status in patients with vulvar cancer.
G. Garganese   +13 more
semanticscholar   +1 more source

Incidence patterns and temporal trends of invasive nonmelanotic vulvar tumors in Germany 1999-2011. A population-based cancer registry analysis. [PDF]

open access: yesPLoS ONE, 2015
Time trends on the incidence and characteristics of invasive vulvar cancer in Germany have so far been studied in few local population- and hospital based tumor registries.
Nina Buttmann-Schweiger   +6 more
doaj   +1 more source

Sensor technologies in cancer research for new directions in diagnosis and treatment: and exploratory analysis [PDF]

open access: yesarXiv, 2022
The goal of this study is an exploratory analysis concerning main sensor technologies applied in cancer research to detect new directions in diagnosis and treatments. The study focused on types of cancer having a high incidence and mortality worldwide: breast, lung, colorectal and prostate.
arxiv  

The use of human adipose-derived stem cells in the treatment of physiological and pathological vulvar dystrophies [PDF]

open access: yes, 2016
“Vulvar dystrophy” is characterized by chronic alterations of vulvar trophism, occurring in both physiological (menopause) and pathological (lichen sclerosus, vulvar graft-versus-host disease) conditions.
CARELLA, SARA   +4 more
core   +4 more sources

High-risk human papillomavirus-associated vulvar neoplasia among women living with human immunodeficiency virus in Zambia

open access: yesAfrican Journal of Laboratory Medicine, 2022
Background: Globally, women living with HIV have a higher risk of vulvar neoplasia than HIV-negative women. Vulvar neoplasia among women living with HIV has not previously been characterised in Zambia.
Fred Maate   +6 more
doaj   +1 more source

Linking type 2 diabetes and gynecological cancer: An introductory overview [PDF]

open access: yes, 2018
Type 2 diabetes (T2D) is a chronic disease with a growing prevalence and a leading cause of death in many countries. Several epidemiological studies observed an association between T2D and increased risk of many types of cancer, such as gynecologic ...
Anastasi, Emanuela   +5 more
core   +1 more source

Vulvar cancer in Botswana in women with and without HIV infection: patterns of treatment and survival outcomes

open access: yesInternational Journal of Gynecological Cancer, 2021
Objectives Vulvar cancer is a rare gynecological malignancy. However, the incidence of human papillomavirus (HPV)-associated vulvar disease is increasing, particularly in low- and middle-income countries.
E. MacDuffie   +12 more
semanticscholar   +1 more source

Incidence and survival of gynecologic cancer including cervical, uterine, ovarian, vaginal, vulvar cancer and gestational trophoblastic neoplasia in Korea, 1999–2019: Korea Central Cancer Registry [PDF]

open access: yesObstetrics & Gynecology Science, 2023
Objective To investigate the incidence, trends, and survival rates of all gynecologic cancers using the Korea Central Cancer Registry (KCCR) database from 1999–2019.
Bo Seong Yun   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy